Warsaw Company Invests in California Tech
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowWarsaw-based Nextremity Solutions Inc. has reached an agreement with a high-tech California company. The deal with Molecular Matrix Inc. will give Nextremity Solutions exclusive global rights to MMI’s GroCell-3D technology and future musculoskeletal technologies for use below the knee.
Nextremity Solutions says the GroCell-3D technology grows mammalian cells and tissues on a three dimensional scaffold as well as supporting the growth of bone, cartilage, heart, nerves, liver, and stem cells.
Nextremity says it has invested in the California company and Nextremity Chief Financial Officer Frank Patton will join the MMI board.
Nextremity Chief Executive Officer Nick Deeter says "when I first heard about this technology I knew Nextremity Solutions needed to find a way to work with Molecular Matrix. When you really think about all of the ways this technology could be used in the treatment of foot and ankle degenerative diseases and deformities, you realize that this industry is about to change. We are privileged to partner with the amazing and innovative team at Molecular Matrix."
The technology will be available as part of the Nextremity portfolio next year.